Robert Beach, MD | |
301 University Blvd, Galveston, TX 77555-1022 | |
(409) 772-2222 | |
Not Available |
Full Name | Robert Beach |
---|---|
Gender | Male |
Speciality | |
Experience | Years |
Location | 301 University Blvd, Galveston, Texas |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1205929379 | NPI | - | NPPES |
132337003 | Medicaid | TX |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RN0300X | Internal Medicine - Nephrology | G2639 (Texas) | Primary |
Mailing Address | Practice Location Address |
---|---|
Robert Beach, MD 301 University Blvd, Galveston, TX 77555-5302 Ph: (409) 772-2222 | Robert Beach, MD 301 University Blvd, Galveston, TX 77555-1022 Ph: (409) 772-2222 |
News Archive
Kiadis Pharma B.V., a clinical stage biopharmaceutical company developing treatments for blood cancers, today announces the successful Phase II enrollment of approximately ten patients of whom the majority have already been transplanted and received ATIRâ„¢. Kiadis Pharma's lead program, ATIRâ„¢, is a cell-based product designed to enable stem cell transplantations from partially mismatched (haploidentical) family donors for blood cancer patients who do not have a standard of care stem cell donor available. Topline data from the trial (CR-AIR-007) is expected in the first half of 2014.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, owing to the emergence of new agents that have the potential to affect disease progression, the Alzheimer's disease drug market will more than triple, from $4.3 billion in 2009 to $13.3 billion in 2019 in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan.
Meda Pharmaceuticals Inc. today announced that the US Food and Drug Administration (FDA) has approved ASTEPRO(R) (azelastine HCl) Nasal Spray 0.15%, for the treatment of the symptoms of seasonal and perennial allergic rhinitis (SAR and PAR). New ASTEPRO Nasal Spray 0.15% is the first nasal antihistamine to offer convenient once-daily dosing for patients who suffer from seasonal allergies.
University of California, San Diego NanoEngineers won a grant from the National Institutes of Health (NIH) to develop the tools to manufacture biodegradable frames around which heart tissues functional blood vessels included will grow.
› Verified 8 days ago
Dr. James Harold Pavela, MD Nephrology Medicare: Medicare Enrolled Practice Location: 301 University Blvd, Galveston, TX 77555 Phone: 409-772-7063 Fax: 409-747-8579 | |
Diaa Hamouda, MBBCH Nephrology Medicare: Accepting Medicare Assignments Practice Location: 301 University Blvd, Jsa 9.128, Galveston, TX 77555 Phone: 409-772-8031 Fax: 409-772-6940 | |
Syed Mustajab Hasan, MD Nephrology Medicare: Not Enrolled in Medicare Practice Location: 1005 Harborside Drive, Galveston, TX 77555 Phone: 409-762-2328 Fax: 832-632-7866 | |
Arielle Degueure, MD Nephrology Medicare: Medicare Enrolled Practice Location: 301 University Blvd, Galveston, TX 77555 Phone: 409-747-1883 Fax: 409-747-8579 | |
Dr. Shawn Pua Eiko Nishi, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 301 University Blvd, Galveston, TX 77555 Phone: 409-643-4587 | |
Suyuan Tan, Nephrology Medicare: Medicare Enrolled Practice Location: 301 University Blvd, Galveston, TX 77555 Phone: 409-747-1883 | |
Shahzad Jokhio, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 301 University Blvd, Galveston, TX 77555 Phone: 409-722-2222 |